RNA modifications: importance in immune cell biology and related diseases

L Cui, R Ma, J Cai, C Guo, Z Chen, L Yao… - Signal transduction and …, 2022‏ - nature.com
RNA modifications have become hot topics recently. By influencing RNA processes,
including generation, transportation, function, and metabolization, they act as critical …

Chemically modified platforms for better RNA therapeutics

Y Shi, X Zhen, Y Zhang, Y Li, S Koo, Q Saiding… - Chemical …, 2024‏ - ACS Publications
RNA-based therapies have catalyzed a revolutionary transformation in the biomedical
landscape, offering unprecedented potential in disease prevention and treatment. However …

The potential role of N7-methylguanosine (m7G) in cancer

Y Luo, Y Yao, P Wu, X Zi, N Sun, J He - Journal of hematology & oncology, 2022‏ - Springer
Abstract N 7-methylguanosine (m7G), one of the most prevalent RNA modifications, has
recently attracted significant attention. The m7G modification actively participates in …

QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism

Z Zhao, Y Qing, L Dong, L Han, D Wu, Y Li, W Li, J Xue… - Cell, 2023‏ - cell.com
Summary N 7-methylguanosine (m 7 G) modification, routinely occurring at mRNA 5′ cap
or within tRNAs/rRNAs, also exists internally in messenger RNAs (mRNAs). Although m 7 G …

RNA modifications in cancer

Q Tang, L Li, Y Wang, P Wu, X Hou, J Ouyang… - British journal of …, 2023‏ - nature.com
Currently, more than 170 modifications have been identified on RNA. Among these RNA
modifications, various methylations account for two-thirds of total cases and exist on almost …

N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis

H Han, C Yang, J Ma, S Zhang, S Zheng, R Ling… - Nature …, 2022‏ - nature.com
Mis-regulated RNA modifications promote the processing and translation of oncogenic
mRNAs to facilitate cancer progression, while the molecular mechanisms remain unclear …

METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma

M Huang, J Long, Z Yao, Y Zhao, Y Zhao, J Liao… - Cancer …, 2023‏ - aacrjournals.org
The tyrosine kinase inhibitor lenvatinib is a first-line drug for treating patients with advanced
hepatocellular carcinoma (HCC). However, its efficacy is severely hampered by drug …

RNA modification: mechanisms and therapeutic targets

L Qiu, Q **g, Y Li, J Han - Molecular biomedicine, 2023‏ - Springer
RNA modifications are dynamic and reversible chemical modifications on substrate RNA
that are regulated by specific modifying enzymes. They play important roles in the regulation …

tRNA dysregulation and disease

EA Orellana, E Siegal, RI Gregory - Nature Reviews Genetics, 2022‏ - nature.com
Abstract tRNAs are key adaptor molecules that decipher the genetic code during translation
of mRNAs in protein synthesis. In contrast to the traditional view of tRNAs as ubiquitously …

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting

YN Qi, Z Liu, LL Hong, P Li, ZQ Ling - Journal of hematology & oncology, 2023‏ - Springer
RNA modification has recently become a significant process of gene regulation, and the
methyltransferase-like (METTL) family of proteins plays a critical role in RNA modification …